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Abstract
There is an emerging trend in the reinforcement learning for healthcare literature.
In order to prepare longitudinal, irregularly sampled, clinical datasets for rein-
forcement learning algorithms, many researchers will resample the time series
data to short, regular intervals and use last-observation-carried-forward (LOCF)
imputation to fill in these gaps. Typically, they will not maintain any explicit
information about which values were imputed. In this work, we (1) call atten-
tion to this practice and discuss its potential implications; (2) propose an alterna-
tive representation of the patient state that addresses some of these issues; and
(3) demonstrate in a novel but representative clinical dataset that our alternative
representation yields consistently better results for achieving optimal control, as
measured by off-policy policy evaluation, compared to representations that do not
incorporate missingness information.
1 Introduction
Recent work in reinforcement learning (RL) for health-related problems has highlighted some of the
promises and pitfalls of the RL approach for clinical data [16, 22, 24, 33, 39, 45]. An important
but perhaps understated fact throughout this literature is that how one models the patient health
state matters: policies learned under one patient state representation may differ dramatically from
another, even though the two policies are ultimately learned from the same underlying raw data [17].
An added difficulty is that traditional methods in reinforcement learning are not well-adapted to
missingness and the irregular sampling frequencies so commonly observed in clinical data [34, 41].
RL methods offer a promising framework for optimizing sequences of treatment decisions in the
clinic, but these methods will only succeed if they have access to adequate representations of the
patient state.
One emerging trend in the recent offline reinforcement learning for healthcare literature is to prepro-
cess the clinical data by discretizing and resampling observations into regular time intervals using
“Last-Observation-Carried-Forward” (LOCF) imputation [10]. In this regime, one substitutes a miss-
ing value (e.g. heart rate) with the last observed value for that variable [15]. However, few of the
reinforcement learning for healthcare papers which utilize LOCF imputation mention any use of
methods to leverage missingness information [21, 26, 30, 35]. Here, we explore the impact of this
choice and potential alternatives. Our results suggest that (1) dynamics of the patient health state
differ significantly between periods of more frequent missingness and less frequentmissingness, and
(2) incorporating missingness information into the patient state representation can improve policy
performance, as measured by off-policy policy evaluation (OPPE).
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2 Background and Related Work
While researchers have rigorously analyzed the theory of missing data and its implications [37,
38], missingness in electronic health record (EHR) data specifically is less well studied. Early
indications suggest, however, that missingness information is a critical component of any adequate
patient time series representation. This may be because missingness can provide insight into the
true (but unobserved) value of the missing entity itself as well as more general information about
the patient’s health state. Supporting this idea, [5] explored patterns of missingness in an EHR
dataset and found that a substantial portion of common laboratory values appeared not to be Missing
Completely at Random (where observed/missing data would have the same distribution), but rather
Missing at Random (where systematic differences between the missing and observed values can
occur when considered in isolation, but these differences are fully explained by other observed
variables). This has important implications. [9] found that rates of missingness for many variables
in the MIMIC-III dataset were highly correlated with ICD-9 and diagnosis categories. [1] found that
patients with higher rates of missingness in variables related to an Acute Physiology Score (APS)
experienced lower mortality rates compared to those with lower rates of missingness, even after
controlling for patients’ severity of illness.
Why might missing values appear in a patient time series extracted from the EHR, and how might
they give rise to the above phenomena? We suggest at least two potential mechanisms for miss-
ingness, each informative in its own way. The first essentially arises as an artifact of binning a
multidimensional time series into discrete windows: if one laboratory test is administered every 24
hours, another every 6 hours, and we bin the patient time series into 4-hour windows, then inevitably
some windows will have missing entries for the two tests. Note, however, that if a laboratory test is
administered more frequently in sick individuals than in healthy individuals, then rates of missing-
ness for the test will be higher in healthy (less frequently tested) individuals under a fixed binning
scheme. Missingness in this context may therefore be a proxy for testing frequency, which in turn
can be informative of a patient’s overall health. An illustrative example where more frequent sam-
pling (and, consequently, lower rates of missingness in the medical record) is associated with poorer
health is given by [11].
A second mechanism of missingness arises when a particular laboratory test is only administered
(or not administered) if the ordering physician has a suspicion about some aspect of the patient’s
health. For example, ICU doctors will often order an erythrocyte sedimentation rate (ESR) test on
a patient for whom they suspect inflammation or infection [6, 13]. The absence of an ESR value
in the EHR, then, could indicate that the clinician did not suspect infection or inflammation. This
gives additional information about the patient’s health state. Illustrating how broad and systematic
this mechanism of missignness can be in the EHR, [2] found that just the presence of a laboratory
test in a patient’s EHR - completely ignoring its actual value - was significantly associated with odds
of survival for 86% of the 272 common clinical laboratory tests they analyzed.
In aggregate, current literature supports the notion of "informative missingness" [9, 38], i.e. that
missingness itself carries important information about both the value of the missing entity and the
patient state. Given the recent attention on reinforcement learning methods as an approach for
analyzing longitudinal EHR data, an important lingering question concerns how exactly one should
handle missing values in these types of studies. Several approaches from the non-RL literature
deserve consideration. [9] developed a unique LSTM structure that incorporates information about
a variable’s missingness and time since last observation and demonstrated that their model improves
predictive performance. [3], [40], and [25] all demonstrate that even just the simple practice of
including in the feature set an indicator to identify when imputed variables were originally missing
can significantly improve performance of predictive models for critical patient outcomes. In this
paper, for the sake of illustration and to encourage adoption in practice, we lean toward simple
methods over relatively complex ones for incorporating missingness information into the patient
state representation and therefore take the latter approach. To the best of our knowledge, ours is
the first work to evaluate the impact of including a post-imputation indicator for missingness in the
representation of the patient state for applications of reinforcement learning to healthcare data.
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Table 1: Mann-Whitney U Test evaluating whether aPTT dynamics are significantly different under
concurrent laboratory test missingness vs. non-missingness. (bold: significant after family-wise
error rate control ). Only significant results are shown here; see Table 3 in Appendix for full results.
Concurrent Lab, L MedianXL,missing MedianXL,not missing p-value
Prothrombin Time (PT) 27.10 35.44 1.61e-10
International Normalized Ratio (INR) 27.10 35.44 1.61e-10
Total Bilirubin (TBILI) 32.71 36.21 2.01e-4
Aspartate Aminotransferase (AST) 32.67 36.24 2.12e-4
Alanine Aminotransferase (ALT) 32.71 36.23 2.57e-4
Erythrocyte Sedimentation Rate (ESR) 34.99 39.13 2.20e-5
3 Dataset
We extracted EHR data from the STRIDE database [27] for 8,983 ICU patients who underwent
unfractionated heparin (UFH) anticoagulation therapy between 2012 and 2018. UFH is an important
anticoagulant delivered to ICU patients who are at risk of developing venous thromboembolism
(VTE) – blood clots that can form in a patient’s veins and block the flow of blood to critical organs.
In consultation with a clinical care team, all laboratory values deemed relevant to optimal UFH
dosing decisions were included in our analysis. Observations in the dataset were defined based on
the times at which a physician simultaneously requested an anti-Xa chromogenic assay (anti-Xa)
and activated partial thromboplastin time (aPTT) laboratory tests, as these two tests are the standard
protocol for UFH monitoring at Stanford Hospital. These orders are frequently made concurrently
with a suite of other laboratory tests relevant to the task of UFH dosing, including those listed in
Table 1.
The example of UFH dosing is representative of a broader class of optimal control problems often
encountered in clinical settings. If a doctor gives a patient too much UFH, they can put the patient
at risk of excessive and dangerous bleeding. If the doctor does not give the patient enough UFH,
they may increase the patient’s risk of developing a VTE [20]. For this reason, doctors typically
try to titrate a patient’s UFH dosage so as to maintain the values of laboratory tests which measure
clotting tendency, namely aPTT and anti-Xa, within target therapeutic ranges [4]. Abnormalities
in liver function, however, as measured by tests like ALT, AST, and TBILI (see Table 1) may alter
metabolism of UFH. This can lead to deceptive or unstable aPTT values [43] as well as other more
serious complications [36]. For this reason, the presence of a lab value like TBILI in a patient’s
EHR may suggest that the patient is unstable or that the doctor is concerned about more serious
underlying physiological issues. Vice versa, the absence of such a lab value may indicate relative
stability.
4 Models and Methods
Statistical testing. Given that aPTT values in particular are known to be susceptible to aberrations
in liver function, we first tested the hypothesis of whether the dynamics of aPTT, one of the lab values
that clinicians would like to keep in control, are significantly different when one of the concurrently-
measured laboratory tests is missing vs. not missing. In order to do this, we computed:
XL,missing = {|aPTTt+1 − aPTTt−1| : Lt missing} (1)
XL,not missing = {|aPTTt+1 − aPTTt−1| : Lt not missing} (2)
where Lt represents the value of laboratory test L (e.g. total bilirubin) corresponding to an observa-
tion taken at time t, aPTTt−1 represents the observed aPTT value one observation before this time
point, and aPTTt+1 represents the observed aPTT value one observation after. We then performed
a one-sided Mann-Whitney U test [28], testing against the null hypothesis that a randomly drawn
observation from XL,missing is equally likely to be less than or greater than a randomly drawn
observation from XL,not missing . Significant findings from this analysis (after controlling for mul-
tiple hypothesis tests with Bonferroni correction ) can be found in Table 1, with full results in the
Appendix (Table 3).
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Table 2: Impact of Including Missingness Information in Patient State Representation on Off-Policy
Policy Optimization (OPPO) and Off-Policy Policy Evaluation (OPPE). Numbers reported are the
average± 1 standard deviation of OPPE estimates over the validation folds from 5-fold CV.
Missingness Information Used? Expected Return (Off-Policy Evaluation)
OPPO OPPE Standard IS Standard WIS Stepwise IS Stepwise WIS
No No -0.547± 0.074 -2.159± 0.236 -1.137 ± 0.097 -3.843 ± 0.156
No Yes -0.538± 0.076 -2.155± 0.246 -1.118 ± 0.100 -3.838 ± 0.178
Yes Yes -0.504 ± 0.086 -2.049 ± 0.253 -1.046 ± 0.108 -3.710 ± 0.232
Reinforcement learning. We assessed the impact of including missingness information in the
patient state representation on the performance of both Off-Policy Policy Optimization (OPPO) with
Fitted Q-Iteration and Off-Policy Policy Evaluation (OPPE) with several Inverse Propensity Scoring
(IPS) methods. We defined a reward at each step of the trajectory based on whether or not a patient’s
aPTT and anti-Xa values fell within what is considered to be a “therapeutic range”. Both aPTT and
anti-Xa measure the patient’s blood’s propensity to coagulate inappropriately (e.g. too slowly or too
quickly). Clinical guidelines suggest that therapeutic ranges are 40 to 80 seconds for aPTT and 0.3
to 0.7 IU/mL for anti-Xa. In each step of a trajectory we define the reward as a sum of -1 for every
observation irrespective of the control region (to penalize staying in the ICU), -1 if the patient was
not in the therapeutic range for anti-Xa, and -1 if the patient was not in the therapeutic range for
aPTT.
We split our dataset into 5 folds (randomized by patient ID so that all of a patient’s visits in the
clinic were in the same fold) and performed cross-validation on our entire imputation, OPPO, and
OPPE pipeline for each fold [14, 19]. Thus, for each of the 5 splits of the dataset into training and
validation folds, we performed the following steps: (1) for every variable that exhibited missingness
in the raw dataset, we added a binary indicator to the patient state representation whose value took
on 1 if the corresponding variable was originally missing and 0 otherwise; (2) we performed LOCF
imputation on all missing values in the dataset for which a prior value in the patient’s trajectory
was available; (3) for missing values with no prior value available, we used iterative multivariate
imputation, learning the imputation model from the training folds and applying that model to the
heldout validation fold [7, 8, 32]; (4) we learned an optimal policy from the training folds using
Fitted Q-Iteration with an Extra-Trees regressor [12]; (5) we evaluated that policy on the held-out
validation fold using standard importance sampling (IS), standard weighted importance sampling
(WIS), step-wise IS, and step-wise WIS methods [23]. We used these Inverse Propensity Scoring
(IPS) methods for OPPE because they have theoretical guarantees of consistency under assumptions
of coverage and nonconfounding and are popular in OPPE literature [44]. For each split of the
dataset, we performed OPPO with and without the missingness information indicator followed by
OPPE with and without the missingness indicator. We do not, however, report evaluation metrics
for OPPO with a missingness indicator followed by OPPE without a missingness indicator because
of potential confounding [29].
5 Results and Discussion
Table 1 shows the results of our test for whether the dynamics of aPTT differs under missingness of
concurrent laboratory values. For six laboratory tests we found that the absolute difference between
aPTT values measured just before and just after an aPTT/anti-Xa observation was significantly less,
on average, when the the concurrent lab test was missing compared to when it was not missing.
Notably, half of the concurrent labs found to have this significant effect (namely TBILI, AST, ALT)
are typically used to asses liver damage [31], which is known to disrupt normal aPTT dynamics
[18]. These findings suggest that missingness may be a proxy for aPTT test stability over time, and
could thus be important when learning to make optimal treatment decisions based on patient state
dynamics.
Table 2 shows the effect of including missingness information into the patient state space for OPPO
and OPPE. As a comparison, the average discounted rewards under the clinician’s data-generating
policy was -7.656 ± 0.268. On average, incorporating missingness into the patient state space for
both OPPO and OPPE improved the estimated reward under every IPS method analyzed. The ef-
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fects appear to be additive in the sense that incorporating missingness into the state representation
for OPPE improved estimated performance, and additionally incorporating missingness into OPPO
increased estimated performance even further. Although these findings were provocatively consis-
tent across IPS methods, they were not significant, likely due to known issues of high variance in
OPPE estimators [42]. In accordance with our discussion in Section 2 about "informative missing-
ness", our results suggest that missingness in our dataset may carry important information about the
patient’s health state, and that leveraging this missingness information can potentially improve es-
timated reward under OPPO and OPPE. Researchers applying reinforcement learning to healthcare
datasets may benefit from this simple augmentation to the patient state representation. The code
used to run our analyses can be found at github.com/scottfleming/rl-missingness.
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6 Appendix
Table 3: Mann-Whitney U Test evaluating whether aPTT dynamics are significantly different under
concurrent laboratory test missingness vs. non-missingness. (bold: significant after Bonferroni
correction for controlling the family-wise error rate )
Concurrent Lab, L MedianXL,missing MedianXL,not missing p-value
Prothrombin Time (PT) 27.10 35.44 1.61e-10
International Normalized Ratio (INR) 27.10 35.44 1.61e-10
Total Bilirubin (TBILI) 32.71 36.21 2.01e-4
Creatinine (CR) 27.49 35.27 2.22e-2
Aspartate Aminotransferase (AST) 32.67 36.24 2.12e-4
Alanine Aminotransferase (ALT) 32.71 36.23 2.57e-4
Platelet Count (PLT) 42.48 35.18 0.988
C-reactive Protein (CRP) 35.15 35.53 0.965
Red Cell Distribution Width (RDW) 33.67 35.19 0.561
Hemoglobin (HGB) 40.14 35.18 0.372
White Blood Cell Count (WBC) 33.67 35.19 0.561
Fibrinogen (FBN) 34.27 39.84 0.324
Erythrocyte Sedimentation Rate (ESR) 34.99 39.13 2.20e-5
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